These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27449261)

  • 81. Challenging beliefs of testosterone therapy and prostate cancer.
    Huynh LM; Ahlering TE
    Nat Rev Urol; 2019 Dec; 16(12):699-701. PubMed ID: 31659332
    [No Abstract]   [Full Text] [Related]  

  • 82. Prostate Cancer and Testosterone Replacement Therapy--What is the Risk?
    Carson CC; Kirby R
    J Urol; 2015 Dec; 194(6):1527-8. PubMed ID: 26386278
    [No Abstract]   [Full Text] [Related]  

  • 83. Re: Testosterone replacement therapy and prostate health.
    Kaplan SA
    J Urol; 2013 Oct; 190(4):1333. PubMed ID: 24029342
    [No Abstract]   [Full Text] [Related]  

  • 84. Testosterone therapy in women: myths and misconceptions.
    Glaser R; Dimitrakakis C
    Maturitas; 2013 Mar; 74(3):230-4. PubMed ID: 23380529
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Re: Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy.
    Seftel AD
    J Urol; 2016 Feb; 195(2):441-2. PubMed ID: 26853007
    [No Abstract]   [Full Text] [Related]  

  • 86. Testosterone potentiated 32P therapy in prostatic carcinoma.
    Donati RM; Ellis H; Gallagher NI
    Cancer; 1966 Aug; 19(8):1088-90. PubMed ID: 4161770
    [No Abstract]   [Full Text] [Related]  

  • 87. Men, should you try testosterone therapy?
    Johns Hopkins Med Lett Health After 50; 2011 Feb; 22(12):6-7. PubMed ID: 27024065
    [No Abstract]   [Full Text] [Related]  

  • 88. Clinical results of the treatment of prostatic carcinoma over a ten-year period.
    STAUBITZ WJ; OBERKIRCHER OJ; LENT MH
    J Urol; 1954 Nov; 72(5):939-45. PubMed ID: 13212905
    [No Abstract]   [Full Text] [Related]  

  • 89. Evaluation of TACE as a therapeutic agent in prostatic carcinoma.
    O'CONOR VJ; SOKOL JK
    Q Bull Northwest Univ Med Sch; 1952; 26(2):161-2. PubMed ID: 14930215
    [No Abstract]   [Full Text] [Related]  

  • 90. Unearthing roles for the gut microbiome.
    Fenner A
    Nat Rev Urol; 2018 Oct; 15(10):589. PubMed ID: 30065358
    [No Abstract]   [Full Text] [Related]  

  • 91. Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Con.
    Gleave ME; Klotz L
    J Urol; 2016 Oct; 196(4):985-8. PubMed ID: 27520085
    [No Abstract]   [Full Text] [Related]  

  • 92. The effects of testosterone replacement therapy on the prostate: a clinical perspective.
    Miah S; Tharakan T; Gallagher KA; Shah TT; Winkler M; Jayasena CN; Ahmed HU; Minhas S
    F1000Res; 2019; 8():. PubMed ID: 30828436
    [TBL] [Abstract][Full Text] [Related]  

  • 93. What does the research say about androgen use and cerebrovascular events?
    Sadaie MR; Farhoudi M; Zamanlu M; Aghamohammadzadeh N; Amouzegar A; Rosenbaum RE; Thomas GA
    Ther Adv Drug Saf; 2018 Aug; 9(8):439-455. PubMed ID: 30364888
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
    Traish A
    Investig Clin Urol; 2016 Nov; 57(6):384-400. PubMed ID: 27847912
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Pro.
    Morgentaler A
    J Urol; 2016 Oct; 196(4):985-8. PubMed ID: 27449261
    [No Abstract]   [Full Text] [Related]  

  • 96. Re: Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Seftel AD
    J Urol; 2015 Jun; 193(6):1985-6. PubMed ID: 25986797
    [No Abstract]   [Full Text] [Related]  

  • 97. Testosterone replacement therapy in prostate cancer patients: is it safe?
    Umbas R; Sugiono M
    Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prostate cancer: Testosterone therapy for hypogonadal men with prostate cancer.
    Catarinicchia SP; Crawford ED
    Nat Rev Urol; 2016 Sep; 13(9):497-8. PubMed ID: 27431338
    [No Abstract]   [Full Text] [Related]  

  • 99. Androgen replacement therapy after prostate cancer treatment.
    Khera M
    Curr Urol Rep; 2010 Nov; 11(6):393-9. PubMed ID: 20838944
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Testosterone substitution with special regard to prostate cancer].
    Beintker M; Behre H
    Urologe A; 2008 Dec; 47(12):1588-91. PubMed ID: 18931991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.